PatSnap and Intellegens Announce Strategic Partnership Bringing Real-Time IP Intelligence Into AI-Driven Formulation Design

Patsnap, the global leader in AI-native innovation intelligence for IP and R&D, and Intellegens, a pioneer in advanced machine learning for R&D, today announced a strategic partnership connecting Patsnap's global patent dataset with Intellegens' Alchemite™ Suite. The partnership is designed to give R&D teams in chemicals, materials, and FMCG access to patent insight earlier in the development process, at the point of experimental design rather than after testing is complete.

Formulation development and IP review have traditionally operated as separate functions. Scientists optimize a candidate material or chemical formulation and then submit it for patent clearance, a sequence that can result in weeks of experimental work being forfeited or redirected when a conflict is identified.

Alchemite uses machine learning to predict optimal formulations from sparse experimental data, compressing development cycles by 50% to 80% by directing R&D teams toward the most promising candidates. That compression matters: according to Patsnap's 2026 R&D Benchmark Report, based on responses from 200+ R&D professionals, more than a third of organizations (37%) spend between 25% and 40% of their entire R&D budget on projects that never reach market, and when projects are terminated late in development or testing, 45% of respondents estimate the wasted investment at $1 million or more per project. 

Through the partnership, Intellegens' AI agent, Alchemite Insight, can now validate candidates against Patsnap's database of more than 170 million global patent records for novelty and freedom-to-operate before bench work begins. Where a conflict exists, the system can surface alternative ingredients or process parameters that maintain the performance target while staying clear of protected intellectual property.

The integration runs through Patsnap's Open Platform, which allows AI systems and agents to call its IP intelligence programmatically. This is what allows IP validation to sit natively inside Alchemite's design loop rather than as a separate, manual step.

"Patsnap's R&D customers have consistently flagged the gap between formulation work and IP review as a drag on their go-to-market timelines. This partnership puts IP intelligence where it can influence decisions at the design stage, not after the fact," said Ray Chohan, co-founder of Patsnap.

"By embedding Patsnap's IP intelligence directly into the Alchemite experimental design process, we remove the friction between invention and legal validation," said Ben Pellegrini, CEO of Intellegens. "Scientists don't just get a high-performing formula; they get the confidence that it is a viable, legally clear asset from day one."

Learn more about Patsnap and Intellegens by visiting www.patsnap.com and intellegens.com.

About Patsnap

Founded in Singapore in 2007, Patsnap is a leading global innovation intelligence company. Leveraging domain-specific AI agents and robust analytics tools, Patsnap empowers IP and R&D teams to unlock insights, accelerate discoveries and protect breakthroughs. Trusted by nearly 20,000 enterprises, law firms and research institutions in over 50 countries including one-third of the world’s largest R&D spenders, Patsnap transforms how organizations innovate and make critical decisions. Learn more at www.patsnap.com.

About Intellegens

Intellegens provides unique machine learning software, Alchemite™, designed to solve complex problems with sparse or noisy data. It accelerates the development of novel materials, chemicals, and processes across industries ranging from aerospace to pharmaceuticals. For more information, visit intellegens.com.

Media Contact

Kate White
media@patsnap.com